anti-arrhythmia agents

Preferred Label : anti-arrhythmia agents;

MeSH definition : Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.;

MeSH synonym : drugs, antiarrhythmic; anti-arrhythmia drugs; agents, anti-arrhythmia; antiarrhythmia agents; drugs, anti-arrhythmia; antiarrhythmia drugs; agents, antiarrhythmia; antiarrhythmic drugs; anti arrhythmia drugs; anti arrhythmics; anti-arrhythmics; drugs, antiarrhythmia; anti arrhythmia agents; Antiarrhythmic Drug; Drug, Antiarrhythmic; Anti-Arrhythmia Agent; Agent, Anti-Arrhythmia; Anti Arrhythmia Agent; Anti-Arrhythmia Drug; Anti Arrhythmia Drug; Drug, Anti-Arrhythmia; Antiarrhythmia Agent; Agent, Antiarrhythmia; Antiarrhythmia Drug; Drug, Antiarrhythmia; Anti-Arrhythmic; Anti Arrhythmic;

Wikipedia automatic translation : Antiarrhythmic agent;

MeSH hyponym : antifibrillatory agents; Agents, Antifibrillatory; Antifibrillatory Agent; Agent, Antifibrillatory;

Related MeSH term : cardiac depressants; Depressants, Cardiac; Myocardial Depressants; Depressants, Myocardial; Cardiac Depressant; Depressant, Cardiac; Myocardial Depressant; Depressant, Myocardial;

MeSH annotation : consider also ARRHYTHMIAS, CARDIAC /drug ther;

Wikipedia link : https://en.wikipedia.org/wiki/Antiarrhythmic agent;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D000889;

UMLS CUI

C0003195;

ATC code(s)
- acetyldigitoxin [ATC Code]
- acetyldigoxin, combinations [ATC Code]
- deslanoside [ATC Code]
- digitoxin [ATC Code]
- digoxin [ATC Code]
- tertatolol [ATC Code]
ATC code(s)
- Other antiarrhythmics, class I and III [ATC Code]
- ajmaline [ATC Code]
- amiodarone [ATC Code]
- antiarrhythmics, class I and III [ATC Code]
- antiarrhythmics, class ia [ATC Code]
- antiarrhythmics, class ib [ATC Code]
- antiarrhythmics, class ic [ATC Code]
- antiarrhythmics, class iii [ATC Code]
- aprindine [ATC Code]
- bretylium tosilate [ATC Code]
- bunaftine [ATC Code]
- cibenzoline [ATC Code]
- cymarin [ATC Code]
- disopyramide [ATC Code]
- dofetilide [ATC Code]
- dronedarone [ATC Code]
- encainide [ATC Code]
- flecainide [ATC Code]
- ibutilide [ATC Code]
- lidocaine [ATC Code]
- lorajmine [ATC Code]
- lorcainide [ATC Code]
- metildigoxin [ATC Code]
- mexiletine [ATC Code]
- moracizine [ATC Code]
- prajmaline [ATC Code]
- procainamide [ATC Code]
- propafenone [ATC Code]
- quinidine [ATC Code]
- quinidine, combinations excl. psycholeptics [ATC Code]
- sparteine [ATC Code]
- tedisamil [ATC Code]
- tiracizine [ATC Code]
- tocainide [ATC Code]
- vernakalant [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Afar Language [NCIt concept]
- Antiarrhythmics [ACR pathology]
- Antiarrhythmics [Bloc CIM-11]
- Antiarythmic agents [PASCAL theme]
- Cardiac depressants [ICHI extension code]
- Myocardial depression [ICD-11 More detail]
- Myocardial depression [MedDRA Preferred Term]
- Myocardial dysfunction (disorder) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Antiarrhythmic Agent [NCIt concept]
- Antiarrhythmic agent (substance) [SNOMED CT concept]
- Antidysrhythmic [ICD-11 Extension code]
- antiarrhythmic drug, nos [SNOMED Notion]
Indexing information
- 3-((2-(dipropylamino)-1,2-dipyridin-2-ylethyl)(propyl)amino)propane-1,2-diol [MeSH Supplementary Concept]
- RSD 1019 [MeSH Supplementary Concept]
- SAN2589 [MeSH Supplementary Concept]
- SAN4825 [MeSH Supplementary Concept]
- SAR114646A [MeSH Supplementary Concept]
- Tropisetron [MeSH Descriptor]
- VK-II-36 compound [MeSH Supplementary Concept]
- metylperon [MeSH Supplementary Concept]
- niferidil [MeSH Supplementary Concept]
Record concept(s)
- Anti-Arrhythmia agents [MeSH concept]
- antifibrillatory agents [MeSH concept]
- cardiac depressants [MeSH concept]
See also
- adrenergic beta-antagonists [MeSH Descriptor]
- arrhythmias, cardiac [MeSH Descriptor]
- calcium channel blockers [MeSH Descriptor]
- heart [MeSH Descriptor]
- potassium channel blockers [MeSH Descriptor]
- sodium channel blockers [MeSH Descriptor]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate [MeSH Supplementary Concept]
- 3,4-dihydroxyacetophenone [MeSH Supplementary Concept]
- 3-methoxy-O-demethylencainide [MeSH Supplementary Concept]
- 4-hydroxyphenylethanol [MeSH Supplementary Concept]
- 5-hydroxydecanoic acid [MeSH Supplementary Concept]
- 5-hydroxypropafenone [MeSH Supplementary Concept]
- 6-methyl-2-ethyl-3-hydroxypyridine [MeSH Supplementary Concept]
- AH 23848 [MeSH Supplementary Concept]
- BN 50739 [MeSH Supplementary Concept]
- Dronedarone [MeSH Descriptor]
- DuP 734 [MeSH Supplementary Concept]
- E 4031 [MeSH Supplementary Concept]
- HU 211 [MeSH Supplementary Concept]
- KT 362 [MeSH Supplementary Concept]
- O-demethylencainide [MeSH Supplementary Concept]
- PD 117302 [MeSH Supplementary Concept]
- acebutolol [MeSH Descriptor]
- acecainide [MeSH Descriptor]
- acetyldigitoxins [MeSH Descriptor]
- acetyldigoxins [MeSH Descriptor]
- adenosine [MeSH Descriptor]
- ajmaline [MeSH Descriptor]
- alinidine [MeSH Supplementary Concept]
- allapinin [MeSH Supplementary Concept]
- almokalant [MeSH Supplementary Concept]
- alprenolol [MeSH Descriptor]
- amiodarone [MeSH Descriptor]
- anisodamine [MeSH Supplementary Concept]
- aprindine [MeSH Descriptor]
- atenolol [MeSH Descriptor]
- atropine [MeSH Descriptor]
- azimilide [MeSH Supplementary Concept]
- benzobarbital [MeSH Supplementary Concept]
- bepridil [MeSH Descriptor]
- berbamine [MeSH Supplementary Concept]
- bidisomide [MeSH Supplementary Concept]
- bretylium [MeSH Supplementary Concept]
- bretylium tosylate [MeSH Descriptor]
- bumecain [MeSH Supplementary Concept]
- bunaftine [MeSH Descriptor]
- bupranolol [MeSH Descriptor]
- butobendin [MeSH Supplementary Concept]
- canadine [MeSH Supplementary Concept]
- cardiac glycosides [MeSH Descriptor]
- cariporide [MeSH Supplementary Concept]
- carteolol [MeSH Descriptor]
- celiprolol [MeSH Descriptor]
- changrolin [MeSH Supplementary Concept]
- cicletanine [MeSH Supplementary Concept]
- cifenline [MeSH Supplementary Concept]
- clofilium [MeSH Supplementary Concept]
- cyclopiazonic acid [MeSH Supplementary Concept]
- cymarine [MeSH Descriptor]
- dauricine [MeSH Supplementary Concept]
- deslanoside [MeSH Descriptor]
- detajmium [MeSH Supplementary Concept]
- dicarbine [MeSH Supplementary Concept]
- diethylamino-ethmozine [MeSH Supplementary Concept]
- digitalis glycosides [MeSH Descriptor]
- digitoxin [MeSH Descriptor]
- digoxin [MeSH Descriptor]
- digoxin-like factors [MeSH Supplementary Concept]
- dihydroalprenolol [MeSH Descriptor]
- diprafenone [MeSH Supplementary Concept]
- disopyramide [MeSH Descriptor]
- dofetilide [MeSH Supplementary Concept]
- enadoline [MeSH Supplementary Concept]
- encainide [MeSH Descriptor]
- enkephalin, Met(2)-ProNH2(5)- [MeSH Supplementary Concept]
- enkephalin, ala(2)-mephe(4)-gly(5)- [MeSH Descriptor]
- enkephalin-Leu, Ala(2)-Arg(6)- [MeSH Supplementary Concept]
- ethacizine [MeSH Supplementary Concept]
- ethylisopropylamiloride [MeSH Supplementary Concept]
- falipamil [MeSH Supplementary Concept]
- felodipine [MeSH Descriptor]
- fenozan [MeSH Supplementary Concept]
- flecainide [MeSH Descriptor]
- fosinoprilat [MeSH Supplementary Concept]
- fructose-1,6-diphosphate [MeSH Supplementary Concept]
- gidazepam [MeSH Supplementary Concept]
- glimepiride [MeSH Supplementary Concept]
- heptacaine [MeSH Supplementary Concept]
- honokiol [MeSH Supplementary Concept]
- hydroquinidine [MeSH Supplementary Concept]
- hyoscyamine [MeSH Descriptor]
- ibutilide [MeSH Supplementary Concept]
- indenolol [MeSH Supplementary Concept]
- landiolol [MeSH Supplementary Concept]
- lappaconitine [MeSH Supplementary Concept]
- lidocaine [MeSH Descriptor]
- lorajmine [MeSH Descriptor]
- lorcainide [MeSH Supplementary Concept]
- losartan [MeSH Descriptor]
- losartan carboxylic acid [MeSH Supplementary Concept]
- magnesium sulfate [MeSH Descriptor]
- magnolol [MeSH Supplementary Concept]
- medigoxin [MeSH Descriptor]
- metipranolol [MeSH Descriptor]
- metoprolol [MeSH Descriptor]
- mexiletine [MeSH Descriptor]
- moricizine [MeSH Descriptor]
- nadolol [MeSH Descriptor]
- nicorandil [MeSH Descriptor]
- nifekalant [MeSH Supplementary Concept]
- nizofenone [MeSH Supplementary Concept]
- otenzepad [MeSH Supplementary Concept]
- oxprenolol [MeSH Descriptor]
- oxymatrine [MeSH Supplementary Concept]
- phenazepam [MeSH Supplementary Concept]
- pilsicainide [MeSH Supplementary Concept]
- pirmenol [MeSH Supplementary Concept]
- practolol [MeSH Descriptor]
- prajmaline [MeSH Descriptor]
- pranolium [MeSH Supplementary Concept]
- procainamide [MeSH Descriptor]
- propafenone [MeSH Descriptor]
- propisomide [MeSH Supplementary Concept]
- propranolol [MeSH Descriptor]
- quinidine [MeSH Descriptor]
- recainam [MeSH Supplementary Concept]
- rilmakalim [MeSH Supplementary Concept]
- scoparone [MeSH Supplementary Concept]
- sematilide [MeSH Supplementary Concept]
- sesamodil [MeSH Supplementary Concept]
- sotalol [MeSH Descriptor]
- sparteine [MeSH Descriptor]
- spiradoline [MeSH Supplementary Concept]
- sulotroban [MeSH Supplementary Concept]
- talinolol [MeSH Supplementary Concept]
- tedisamil [MeSH Supplementary Concept]
- terikalant [MeSH Supplementary Concept]
- tertatolol [MeSH Supplementary Concept]
- tetrahydropalmatine [MeSH Supplementary Concept]
- thiazolidine-4-carboxylic acid [MeSH Supplementary Concept]
- thymogen [MeSH Supplementary Concept]
- tilisolol [MeSH Supplementary Concept]
- timolol [MeSH Descriptor]
- tiracizine [MeSH Supplementary Concept]
- tocainide [MeSH Descriptor]
- tyrosyl-arginyl-phenylalanyl-lysinamide [MeSH Supplementary Concept]
- verapamil [MeSH Descriptor]
Validated automatic mappings to BTNT
- Cardiac depressants [ICD-11 Extension code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients